Health Care

Framingham State University and private family foundation Accelerate the Future together received a $1.39-million grant from the Massachusetts Executive Office of Health and Human Services to improve the pipeline of trained behavioral health professionals.

Mercy BioAnalytics, Inc. promoted its chief operating officer, Dawn Mattoon, to the CEO position. Former CEO and Co-founder Paul Blavin transitioned to vice chairman of the board.

Stephanie Page, executive director of Abby Kelley Foster House, Inc is stepping down from the role after nine years. Page will officially leave the role on June 30.

Acton-based Insulet, a medical device firm specializing in diabetes treatment, has acquired $25 million in assets from Automated Glucose Control LLC in California.

Bay State Commons in Westborough was sold for $11 million to a Framingham development partnership.

Dr. Michael Green, vice provost for strategic research initiatives, and professor and chair of molecular, cell and cancer biology at UMass Chan Medical School in Worcester, has died.

Acton medical device firm Insulet has acquired $25 million of diabetes pump technology from California-based Bigfoot Biomedical, nearly doubling Insulet’s intellectual property.

The Worcester Business Journal editorial staff is seeking reader input for this year's Power 50, the publication’s annual list of the most influential professionals in Central Massachusetts.

Allurion Technologies, Inc., the Natick-based creator of the Allurion gastric balloon, will become a publicly traded company, through a deal with Compute Health Acquisition Corp. of Delaware.

Labor challenges across the health care landscape feature as one of the primary areas of attention for the Health Policy Commission this year, and industry leaders and business groups suggested Wednesday that the problem is potent enough to cut across the rest of the regulatory agency's priorities.